1 completed, 1 not yet recruiting, 1 unknown. 3 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Unknown 1 |
Follow Serine: new trials by email Literature Review of Serine trials Research Report on Serine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Serine/Glycine-Restricted Diet With Chemoradiotherapy for Rectal Cancer Serine/Glycine-Restricted Diet, CAPOX Chemotherapy, PD-1 Inhibitor - Locally Advanced Rectal Cancer (LARC) | Phase 1 / Phase 2 | Not yet recruiting | Xuelei Ma MD | 140 | 2026-08-31 | 2026-09-09 |
| L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1 L-serine, placebo - Hereditary Sensory and Autonomic Neuropathy Type I | Phase 1 / Phase 2 | Completed | Massachusetts General Hospital | 18 | 2013-09-01 | 2018-09-12 |
| Determining the Safety of L-serine in ALS L-Serine - Amyotrophic Lateral Sclerosis (ALS) | Phase 1 / Phase 2 | Unknown | Phoenix Neurological Associates, LTD | 20 | 2013-01-01 | 2015-07-30 |
Amyotrophic Lateral Sclerosis (1) · Hereditary Sensory and Autonomic Neuropathies (1)
Massachusetts General Hospital (1) · Phoenix Neurological Associates, LTD (1) · Xuelei Ma MD (1)
United States (2) · China (1)
Florian S Eichler, MD (1) · Todd D Levine, MD (1)